Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
The Journal of Allergy and Clinical Immunology. in Practice|March 1, 2026
The Impact of Treatable Traits on Clinical Remission in Patients with AsthmaChieko Yoshida, Kei Muramoto, Moriyasu Anai, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|November 27, 2004
Is the ratio of transmitral peak E-wave velocity to color flow propagation velocity useful for evaluating the severity of heart failure in atrial fibrillation?Rikimaru Oyama, Kazuya Murata, Nobuaki Tanaka, et al.Viruses|February 28, 2023
HAS-Flow May Be an Adequate Method for Evaluating Human T-Cell Leukemia Virus Type 1 Infected Cells in Human T-Cell Leukemia Virus Type 1-Positive Rheumatoid Arthritis Patients Receiving Antirheumatic Therapies: A Retrospective Cross-Sectional Observation StudyKunihiko Umekita, Yuki Hashikura, Akira Takaki, et al.Journal of Atherosclerosis and Thrombosis|June 25, 2011
Add-on therapy of EPA reduces oxidative stress and inhibits the progression of aortic stiffness in patients with coronary artery disease and statin therapy: a randomized controlled studyAkira Takaki, Seiji Umemoto, Kaoru Ono, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|April 26, 2006
Tricuspid pouch can cause systemic embolization in adulthoodAkira Takaki, Hiroshi Ogawa, Takatoshi Wakeyama, et al.International Journal of Molecular Sciences|December 23, 2020
Heterogeneous Tumor-Immune Microenvironments between Primary and Metastatic Tumors in a Patient with <i>ALK</i> Rearrangement-Positive Large Cell Neuroendocrine CarcinomaTakahiro Tashiro, Kosuke Imamura, Yusuke Tomita, et al.Clinical Cardiology|August 16, 2003
Coronary arterial remodeling in differing clinical presentations of unstable angina pectoris--an intravascular ultrasound studyTakahiro Iwami, Toshihiko Nishioka, Michael C Fishbein, et al.International Journal of Molecular Sciences|November 26, 2022
Clinical Implications and Molecular Characterization of Drebrin-Positive, Tumor-Infiltrating Exhausted T Cells in Lung CancerKosuke Imamura, Yusuke Tomita, Ryo Sato, et al.Lung Cancer (Amsterdam, Netherlands)|May 11, 2025
Impact of durvalumab re-administration after moderate symptomatic pneumonitis in locally advanced non-small cell lung cancerYosuke Kakiuchi, Koichi Saruwatari, Takaaki Tokito, et al.Clinical Lung Cancer|August 2, 2024
Real-World Efficacy and Safety of Durvalumab Administration Following Chemoradiotherapy in Elderly Patients With Unresectable Locally Advanced Nonsmall Cell Lung Cancer: A Multicenter, Retrospective StudyYosuke Kakiuchi, Koichi Saruwatari, Kenta Murotani, et al.Pageof 4